PhotoPoint™ photodynamic therapy with local drug delivery eliminates vessel wall cells in arteriovenous graft models

Cardiovascular Radiation Medicine

Volumn 3, Issue 3-4, 2002, Pages 163-168

  Burgher, Julie M ^a   Barton, Jennifer M ^a   Farooq, Michael M ^b   Vasek, Jeff ^a   Scott, Robert W ^a   Freischlag, Julie A ^b   Grove, Robert I ^a  

^a Miravant Medical Technologies   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arteriovenous access graft; AVG; Canine; Intimal hyperplasia; Local drug administration; PDT; Photodynamic therapy; PhotoPoint; Rabbit

Indexed keywords

MV 2101; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS GRAFT; BLOOD VESSEL TRANSPLANTATION; BLOOD VESSEL WALL; CELL POPULATION; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DOSIMETRY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; EXCISION; EXPERIMENTAL MODEL; FEASIBILITY STUDY; INCUBATION TIME; INTIMA; JUGULAR VEIN; LASER; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT; STEM CELL; TISSUE; ANIMAL; ARTERIOVENOUS SHUNT; ARTICLE; BLOOD VESSEL PROSTHESIS; CELL COUNT; DISEASE MODEL; DRUG EFFECT; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; RADIOMETRY; TIME; ULTRASTRUCTURE; VASCULAR PATENCY;

ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; CELL COUNT; DISEASE MODELS, ANIMAL; DOGS; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; JUGULAR VEINS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RABBITS; RADIOMETRY; TIME FACTORS; TUNICA INTIMA; VASCULAR PATENCY;

EID: 0142227750     PISSN: 15221865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-1865(03)00080-5     Document Type: Conference Paper

References (17)

1. Feldman H.I., Kobrin S., Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 7(4):1996;523-535.
2. Gibson K.D., Gillen D.L., Caps M.T., Kohler T.R., Sherrard D.J., Stehman-Breen C.O. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg. 34:2001;694-700.
3. Eknoyan G., Levine N. NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 30(Suppl 3):1997;s140-s191.
4. Patel N.H., Revanur V.K., Khanna A., Hodges C., Jindal R.M. Vascular access for hemodialysis: an indepth review. J Nephrol. 14(3):2001;146-156.
5. Clinical and economic issues in vascular access. 1(1):2002;Ahrens Balwit & Associates (ABA), Wisconsin.
6. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem Photobiol. 55:1992;145-157.
7. Walker J.P., Leitch I., Kim H.S., Yazdi H., Roessler J., Rychnovsky S., Grove R.I., Waksman R. Intracoronary PhotoPoint™ therapy for restenosis. Gomez C.J. American Society for Photobiology 29th Annual Meeting Abstracts. 2001;68 American Society for Photobiology.
8. Grove R.I., Rychnovsky S., Purter M., Heath R., Leitch I., Walker J.P. The PhotoPoint™ catheter based system for the treatment of intimal hyperplasia. Gomez C.J. American Society for Photobiology 29th Annual Meeting Abstracts. 2001;68-69 American Society for Photobiology.
9. Gonschoir P., Vogel-Wiens C., Goetz A.E., Huehns T.Y., Breger F., Gerheuser F., Fleuchaus M., Welsch U., Sroka R., Dellian M., Lehr H.A., Hofling B. Endovascular catheter-delivered photodynamic therapy in an experimental response to injury model. Basic Res Cardiol. 92:1997;310-319.
10. Grove R.I., Leitch I., Rychnovsky S., Walker J. Current status of photodynamic therapy for the prevention of restenosis. Waksman R. Vascular brachytherapy. 3rd ed:2002;339-345 Futura Publishing, New York.
11. Barton J.M., Nielsen H.V., Rychnovsky S., Farooq M., Freischlag J., Grove R. PhotoPoint™ PDT inhibits intimal hyperplasia in arteriovenous grafts. CRT. 3(3-4):2003;163-169.
12. Gottsauner-Wolf M., Jang Y., Penn M.S., Kaplan A., Ellis S.G., Chisolm G.M., Topol E.J., Lincoff A.M. Quantitative evaluation of local drug delivery using the InfusaSleeve catheter. Catheter Cardiovasc Diagn. 42(1):1997;102-108.
13. Gonschior P., Erdemci A., Gerheuser F., Gonschior G.M., Mack B., Kolbe T., Goetz A.E., Hofling B. Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration. Z Kardiol. 80(12):1991;738-745.
14. Gonschior P., Gerheuser F., Fleuchaus M., Huehns T.Y., Goetz A.E., Welsch U., Sroka R., Dellian M., Lehr H.A., Hofling B. Local photodynamic therapy reduces tissue hyperplasia in an experimental restenosis model. Photochem Photobiol. 64(5):1996;758-763.
15. Adili F., Statius van Eps R.G., Flotte T.J., LaMuraglia G.M. Photodynamic therapy with local photosensitizer delivery inhibits experimental intimal hyperplasia. Lasers Surg Med. 23:1998;263-273.
16. Nagae T., Aizawa K., Ishimaru S., Nakai H., Saito T., Abe M., Fujishima K. Endovascular PDT with Npe6 inhibits restenosis in experimental injured arteries. American Society for Photobiology 29th Annual Meeting Abstracts. 2001;68.
17. Grant W.E., Speight P.M., MacRobert A.J., Hopper C., Brown S.G. Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminum pthalocyanine and 5-aminoaevulinic acid. Br J Cancer. 70:1994;72-78.